News & Events
-
December 12, 2023
eCOA Clinic #1 | Bring Your Own Device (BYOD)
Join us for our first eCOA Clinic! This event offers attendees the chance to bring any questions (or comments) you may have on the topic of BYOD for a panel of experts from eCOA Consortium Members to discuss. This 30-minute eCOA Clinic is brought to you by the eCOA Consortium and is the third offering...... -
November 30, 2023
2023 C-Path Neuroscience Annual Meeting
C-Path’s 2023 Neuroscience Program Annual Meeting is set for Thursday, November 30 in Washington D.C. Bringing stakeholders together from both the Critical Path for Alzheimer’s Disease and the Critical Path for Parkinson’s consortia, this meeting will build off the recent advancements in drug development for Parkinson’s and Alzheimer’s, exploring important opportunities to apply lessons...... -
November 21, 2023
Use of Registries in Regulatory Decision Making
The C-Path team is working to revolutionize the use of real-world data in sharing the future of medical product development in Europe and invite you to: Stay updated on the latest in registry-based healthcare research and data utilization. Understand the European Medicines Agency’s guidelines for registry-based studies. Explore a compelling case study on registry-based real-world...... -
November 1, 2023 - November 4, 2023
Connective Tissue Oncology Society (CTOS) Annual Meeting
Members of the CDRC team will join the CTOS at The Convention Centre Dublin in Ireland. The Connective Tissue Oncology Society was formed in 1995 and incorporated in 1997. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is...... -
October 26, 2023 - October 27, 2023
C-Path to host its Scientific Breakthrough Summit 2023
The summit featured presentations and panel discussions with C-Path collaborators from industry, academia, global regulatory agencies, nurses, parents and patients. The workshop: Explored the unmet needs and potential solutions relevant to specific aspects of type-1 diabetes, alpha-1 antitrypsin deficiency, lysosomal diseases, and neonatal indications. Demonstrated the critical role data sharing plays in enhancing drug development......